| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | US20040005324 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 01/08/2004 | US20040005323 Efficient method for generating human antibodies in particular which are specific to be RSV fusion protein which combines in vitro primary of human spleen cells and antigen boosting in SCID mice is taught. This method provides for very high human |
| 01/08/2004 | US20040005322 Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
| 01/08/2004 | US20040005321 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotheraphy |
| 01/08/2004 | US20040005320 Treating IL-20 induced inflammation. An antagonist to IL-20 is administered to treat inflammation and associated diseases. The antagonist can be an antibody that binds to IL-20 or its receptor or a soluble receptor that binds to IL-20. Adult |
| 01/08/2004 | US20040005318 Method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided. |
| 01/08/2004 | US20040005317 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005315 Administering an immunosuppressive agent that depletes T cells and anti-alpha beta T cell receptor antibodies, and implanting an allograft into the recipient. |
| 01/08/2004 | US20040005314 Apo-2l receptor agonist and cpt-11 synergism |
| 01/08/2004 | US20040005313 Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | US20040005276 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 01/08/2004 | DE10227155A1 Glucan mit TNFα -Ausschüttung induzierender Wirkung, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen Glucan with TNF.alpha -Ausschüttung inducing activity, to processes for its preparation and pharmaceutical compositions containing this |
| 01/08/2004 | CA2844639A1 Method for the treatment of multiple sclerosis |
| 01/08/2004 | CA2542171A1 Modulators and modulation of the interaction between rgm and neogenin |
| 01/08/2004 | CA2492092A1 Immunoglobin single variant antigen-binding domains and dual-specific constructs |
| 01/08/2004 | CA2492057A1 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/08/2004 | CA2491861A1 Human igm antibody lysing activated lymphocytes under mediation by homologous complement |
| 01/08/2004 | CA2491859A1 Human igm antibody inducing apoptosis in hiv-infected cells and remedy for hiv-infection |
| 01/08/2004 | CA2491480A1 Humanized anti-lymphotoxin beta receptor antibodies |
| 01/08/2004 | CA2491427A1 Compositions and methods for therapeutic treatment |
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491094A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 01/08/2004 | CA2491053A1 Use of antibodies against flt-1 for the treatment of osteoporosis |
| 01/08/2004 | CA2490804A1 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 01/08/2004 | CA2490659A1 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490409A1 Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490280A1 Antibodies that specifically bind to reg iv |
| 01/08/2004 | CA2490261A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | CA2490186A1 Method for the treatment of multiple sclerosis |
| 01/08/2004 | CA2489515A1 Methods and compositions for modulating and detecting wisp activity |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378525A2 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378523A1 Anti-cd30 antibodies and uses thereof |
| 01/07/2004 | EP1378521A1 Anti-Carbohydrate Deficient Transferrin (CDT) spezific antibody, its production and use |
| 01/07/2004 | EP1378520A1 Cyclic single strand trispecific antibody |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377832A2 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases |
| 01/07/2004 | EP1377664A2 Genes encoding proteolytic enzymes from aspargilli |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | EP1377311A2 Treatment of neuropathologies associated with expression of tnf-alpha |
| 01/07/2004 | EP1377307A2 Anti-gpe antibodies, their uses, and analytical methods for gpe |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | CN1466464A Novel remedies for cancer |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465596A Establishment of recombination human bone morphogenetic protein-2 microimmunication and antibody preparation thereof |
| 01/07/2004 | CN1465595A Mouse histone human endostatin monoclone antibody |
| 01/07/2004 | CN1465589A Gene recombination SARS virus coat protein S and preparation process thereof |
| 01/07/2004 | CN1465587A Polypeptide-chondriosome carrier 18 and polynucleotide for colding said polypeptide |
| 01/06/2004 | US6673986 Transgenic mouse; deactivated endogenous immunoglobulin heavy chain loci; gene expression |
| 01/06/2004 | US6673916 Phospholipase inhibitors |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673901 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 01/06/2004 | US6673899 Protein for use treatment of diabetes |
| 01/06/2004 | US6673898 Estrone sulfate, dehydroepiandrosterone sulfate and/or ochratoxin a; genetically engineered mutant |
| 01/06/2004 | US6673896 Derivatives of soluble T-4 |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673580 Genetically engineering thrombopoietin for use in the treatment of thrombocytopenia; obtain polypeptide, adjust epitopes, recover polypeptide, administer to patients |
| 01/06/2004 | US6673561 Use in monitoring the treatment of blood disorders in a patient by monitoring changes in the levels of fibrinopeptide b (fpb) in the patient's urine |
| 01/06/2004 | US6673559 Met proto-oncogene and a method for predicting breast cancer progression |
| 01/06/2004 | US6673534 Methods for detection of mutations in myostatin variants |
| 01/06/2004 | US6673355 Administering vaccine to pregnant women; prevention and diagnosis of gastroenteritis, cystic fibrosis, and diarrhea |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673347 Conjugated to polymer via schiff base, hydrazone, oxime, or azomethine compound; diagnosing tumors and metastasis |
| 01/06/2004 | US6673346 Compositions and methods for the treatment of sepsis |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/06/2004 | US6673343 Useful for activating their respective receptor and thereby enabling the role of tyrosine kinase receptor in cell growth and/or differentiation to be studied |
| 01/06/2004 | US6673342 Administering dimeric or polymeric iga antibodies that are for useful in preventing or inhibiting infection by pathogens |
| 01/06/2004 | US6673341 Inhibiting transforming growth factor (tgf-beta) mediated angiogenesis, thereby inhibiting the proliferative disease in vertebrate |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/06/2004 | CA2047721C Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 01/05/2004 | CA2432942A1 Carbohydrate deficient transferrin (cdt)-specific antibodies, their preparation and use |
| 01/02/2004 | EP1375662A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375519A2 Method for affecting cellular function using antibodies |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374901A1 Graft rejection suppressors |
| 01/02/2004 | EP1374900A1 Remedies for infant chronic arthritis-relating diseases |
| 01/02/2004 | EP1374896A1 Blood rheology improving agents |
| 01/02/2004 | EP1374895A2 Pharmaceutical composition of f(ab) 2 fragments of antibodies and method for the preparation thereof |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373547A1 Control of glycoforms in igg |
| 01/02/2004 | EP1373519A2 New elongase gene and production of delta-9-polyunsaturated fatty acids |
| 01/02/2004 | EP1373517A2 Human kinases |